Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials
30 August 2021 (10:45 - 11:00)
Organised by:
About the speaker
TUM Universitätsklinikum, German Heart Center, Munich (Germany)
1 More presentation in this session
Professor R. Byrne (Dublin, IE)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
30 August 2021
10:45 CET
